© 2026 All Rights reserved WUSF
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations
Our daily newsletter, delivered first thing weekdays, keeps you connected to your community with news, culture, national NPR headlines, and more.

Moderna and Merck's mRNA vaccine reduces melanoma recurrence by 42%

Moderna and Merck recently released remarkable new results of their personalized cancer vaccine.

Here & Now‘s Scott Tong speaks with Matthew Herper, a senior writer at STAT, the health and science publication.

This article was originally published on WBUR.org.

Copyright 2026 WBUR

Thanks to you, WUSF is here — delivering fact-based news and stories that reflect our community.⁠ Your support powers everything we do.